These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12749424)

  • 1. Subcutaneous versus intramuscular administration of human chorionic gonadotropin during an in vitro fertilization cycle.
    Stelling JR; Chapman ET; Frankfurter D; Harris DH; Oskowitz SP; Reindollar RH
    Fertil Steril; 2003 Apr; 79(4):881-5. PubMed ID: 12749424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of body mass index and self-administration of hCG on the outcome of IVF cycles: a prospective cohort study.
    Salha O; Dada T; Sharma V
    Hum Fertil (Camb); 2001; 4(1):37-42. PubMed ID: 11591255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periovulatory serum human chorionic gonadotropin (hCG) concentrations following subcutaneous and intramuscular nonrecombinant hCG use during ovulation induction: a prospective, randomized trial.
    Sills ES; Drews CD; Perloe M; Kaplan CR; Tucker MJ
    Fertil Steril; 2001 Aug; 76(2):397-9. PubMed ID: 11476796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization.
    Kovacs P; Kovats T; Bernard A; Zadori J; Szmatona G; Kaali SG
    Fertil Steril; 2008 Dec; 90(6):2133-7. PubMed ID: 18177866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study.
    Humaidan P; Ejdrup Bredkjaer H; Westergaard LG; Yding Andersen C
    Fertil Steril; 2010 Feb; 93(3):847-54. PubMed ID: 19200959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization--embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection.
    Elkind-Hirsch KE; Bello S; Esparcia L; Phillips K; Sheiko A; McNichol M
    Fertil Steril; 2001 Apr; 75(4):700-4. PubMed ID: 11287022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial.
    Kyrou D; Kolibianakis EM; Fatemi HM; Tarlatzis BC; Tournaye H; Devroey P
    Fertil Steril; 2011 Nov; 96(5):1112-5. PubMed ID: 21924414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization.
    Thuesen LL; Loft A; Egeberg AN; Smitz J; Petersen JH; Andersen AN
    Hum Reprod; 2012 Oct; 27(10):3074-84. PubMed ID: 22791754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can in vitro fertilization cycles be salvaged by repeat administration of intramuscular human chorionic gonadotropin the day after failed injection?
    Reichman DE; Greenwood E; Meyer L; Kligman I; Rosenwaks Z
    Fertil Steril; 2012 Sep; 98(3):671-4. PubMed ID: 22769734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety.
    Ashrafi M; Kiani K; Ghasemi A; Rastegar F; Nabavi M
    Arch Gynecol Obstet; 2011 Dec; 284(6):1431-8. PubMed ID: 21210134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
    Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
    J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of follicular fluid analysis in assessment of the main criteria of folliculogenesis in IVF program].
    Tsagareishvili GG
    Georgian Med News; 2005 Feb; (119):18-23. PubMed ID: 15834173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial.
    Serafini P; Yadid I; Motta EL; Alegretti JR; Fioravanti J; Coslovsky M
    Fertil Steril; 2006 Oct; 86(4):830-8. PubMed ID: 16963040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes.
    Laufer N; DeCherney AH; Tarlatzis BC; Zuckerman AL; Polan ML; Dlugi AM; Graebe R; Barnea ER; Naftolin F
    Fertil Steril; 1984 Aug; 42(2):198-203. PubMed ID: 6430722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The empty follicle syndrome: a pharmaceutical industry syndrome.
    Zegers-Hochschild F; Fernández E; Mackenna A; Fabres C; Altieri E; Lopez T
    Hum Reprod; 1995 Sep; 10(9):2262-5. PubMed ID: 8530648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists.
    Kolibianakis EM; Albano C; Camus M; Tournaye H; Van Steirteghem AC; Devroey P
    Fertil Steril; 2004 Jul; 82(1):102-7. PubMed ID: 15236997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live birth of twins after performing early hCG administration as a modification of natural cycle in vitro fertilization, in a women with decreased ovarian reserve.
    Hyman JH; Sokal-Arnon T; Son WY; Tan SL; Dahan MH
    Arch Gynecol Obstet; 2015 Jan; 291(1):219-22. PubMed ID: 25033719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.